接受维持治疗的 ALL 儿童患 COVID-19 疾病:不要忽视风险。
COVID-19 Disease in Children With ALL Receiving Maintenance Therapy: Do Not Discount the Risk.
发表日期:2024 Aug 19
作者:
Alissa R Kahn, Elizabeth S Davis, Chen Dai, Caroline V Caudill, Isaac Martinez, Julienne Brackett, Archana Sharma, Carla Schwalm, Ann Kebede, David S Dickens, Joshua Richman, Susan Colace, , Brook Araya, Smita Bhatia, Julie A Wolfson, Jennifer M Levine, Emily E Johnston
来源:
Immunity & Ageing
摘要:
与大多数儿童癌症不同,ALL 的治疗包括长期的维持阶段,在此期间儿童通常会恢复正常活动。医生需要有关 COVID-19 对该人群的持续影响的数据,以帮助指导大流行后的家庭。儿科肿瘤 COVID-19 病例报告 (POCC) 收集去识别化数据(社会人口统计学、临床数据 [癌症、COVID-19 课程])来自 104 个美国儿科肿瘤机构的儿童、青少年和年轻人患有癌症和 COVID-19。本文介绍的分析将患有 ALL 维持治疗 (ALL-MTN) 的儿童(≤21 岁)与所有其他患有癌症和 COVID-19 的儿童进行了比较。多变量分析根据年龄、种族/族裔、保险、感染时的绝对中性粒细胞计数、疫苗接种和合并症进行调整。与报告给 POCC 的其他儿童 (n = 1,190) 相比,ALL-MTN 中的儿童 (n = 481)较少住院 (23% vs 29%, P = .01) 或住进重症监护室 (ICU: 3% vs 5%, P = .01);这些结果在多变量分析中得到了证实(住院:比值比 [OR],0.7 [95% CI,0.6 至 0.9];ICU:OR,0.5 [95% CI,0.2 至 0.8])。然而,对于 ALL-MTN 儿童,癌症导向治疗的改变更为频繁(50% vs 33%,P ≤ .01;OR,2.0 [95% CI,1.6 至 2.5])。在我们的多变量模型中,疫苗接种是一个独立的预后因素,可降低住院几率(OR,0.7 [95% CI,0.5 至 0.9])。ALL-MTN 中的儿童比其他癌症儿童需要更少的住院治疗和 ICU 入院,但需要更多的治疗调整。接种 COVID-19 疫苗可降低住院几率。
Unlike most childhood cancers, therapy for ALL includes a prolonged maintenance phase during which children typically resume regular activities. Physicians need data regarding the persistent impact of COVID-19 in this population to help guide families after the pandemic.The Pediatric Oncology COVID-19 Case Report (POCC) collects deidentified data (sociodemographics, clinical data [cancer, COVID-19 course]) on children, adolescents, and young adults with cancer and COVID-19 from 104 US pediatric oncology institutions. The analysis presented here compares children (≤21 years) with ALL in maintenance (ALL-MTN) with all other children with cancer and COVID-19. Multivariable analyses adjust for age, race/ethnicity, insurance, absolute neutrophil count at the time of infection, vaccination, and comorbidities.Compared with other children reported to POCC (n = 1,190), those in ALL-MTN (n = 481) were less often hospitalized (23% v 29%, P = .01) or admitted to the intensive care unit (ICU: 3% v 5%, P = .01); these findings persisted in multivariable analysis (hospitalization: odds ratio [OR], 0.7 [95% CI, 0.6 to 0.9]; ICU: OR, 0.5 [95% CI, 0.2 to 0.8]). However, cancer-directed therapy was changed more often for children in ALL-MTN (50% v 33%, P ≤ .01; OR, 2.0 [95% CI, 1.6 to 2.5[). Vaccination was an independent prognostic factor in our multivariable model, decreasing odds of hospitalization (OR, 0.7 [95% CI, 0.5 to 0.9]).Children in ALL-MTN required fewer hospitalizations and ICU admissions but more therapy modifications than other children with cancer. Vaccination against COVID-19 reduced the odds of hospitalization.